2024-2025 Global AI Trends Guide
The transaction aims to strengthen public health objectives by improving vaccine access in Africa by enhancing vaccine production capacity, supporting local supply chains, and establishing a robust network for vaccine distribution in alignment with African Union’s Vision 2040, which seeks to produce 60% of the continent’s vaccine needs locally.
More details on the transaction can be found here and here.
The Hogan Lovells deal team was led by partners Thomas Hechl (Infrastructure, Energy, Resources and Projects - IERP, Washington, D.C.), Olivier Fille-Lambie (IERP, Paris), senior associates Senal Ranatunga (IERP, Washington, D.C.), and Marie-Michèle Banzio (IERP, Paris), and former senior associate Takudzwa Matondo.